Sign in to follow
Search Results

0 results for ''Seeger Weiss''

You can use to get even better search results
April 25, 2007 |

Subprime Crash May Be a Boon to Attorneys

As subprime lenders get ready to confront a host of legal and financial challenges in the coming months, attorneys are preparing for growing workloads. Outside attorneys will be needed to help companies with corporate restructurings, asset sales and bankruptcy filings; guide them through state and federal government probes; and take on class actions by consumers, investors and employees. "We're seeing this hit across multiple practice areas," says Neal, Gerber & Eisenberg's Jerry Biederman.
7 minute read
October 24, 2005 |

Splinters in Vioxx Defense Team

For close to six weeks in the Atlantic City Vioxx trial, lead defense lawyer Diane Sullivan's combative nature has been positively palpable. She has skirmished with the judge at least a half-dozen times in unsuccessful efforts to get information before the jury. She tried it again last Wednesday, but this time the fracas was with her co-counsel, Williams & Connolly's Stephen Raber, at whom she ended up hurling a profanity.
6 minute read
February 08, 2011 |

As Fight Sheds Light on Firm's Woes, Convicted Partner Comes Out Millions Ahead

An arbitration panel has handed Milberg LLP an award stemming from convicted former partner David Bershad's participation in a kickback scheme -- but Bershad has come out ahead financially.
7 minute read
November 03, 2005 |

Merck Wins Big in New Jersey Vioxx Trial

The nation's second trial over health effects of the drug Vioxx got swamped in New Jersey on Nov. 3, as a jury categorically rejected claims that failure to warn about the painkiller's risks caused a user's heart attack.
4 minute read
November 07, 2005 |

Vioxx Verdict Postmortem: Weak Case, Tough Jury

Merck & Co.'s slam-dunk win on Thursday in the nation's second trial over the health effects of its drug Vioxx had as much to do with jury selection and a less-than-sympathetic plaintiff as it did with trial evidence and lawyering, say legal experts who followed the trial.
6 minute read
August 17, 2009 |

Under-the-Skin Pain-Pump Suits Are Removed to Federal Court

Mounting New Jersey litigation over claimed adverse health effects of pain-relieving pumps implanted under the skin has been transferred to federal court.
4 minute read
November 04, 2005 |

Merck Wins Big in New Jersey Vioxx Trial

In the nation's second trial over health effects of the drug Vioxx, the jury on Thursday categorically rejected claims that failure to warn about the painkiller's risks caused a user's heart attack. The jury found that Merck & Co. properly alerted prescribing physicians to cardiovascular risks and committed no consumer-fraud violations in marketing Vioxx to doctors. The verdict enables Merck to overcome the risk of collateral estoppel on the failure-to-warn issue.
4 minute read
November 04, 2005 |

Merck Wins in N.J. Vioxx Trial

The nation's second trial over health effects of the drug Vioxx got swamped in New Jersey yesterday as a jury categorically rejected claims that failure to warn about the painkiller's risks caused a user's heart attack.
4 minute read
Skadden Preserves Merrill Win in ARS Class Action at Second Circuit
Publication Date: 2011-11-14
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Class action litigation over the catastrophic failure of the $330 billion auction-rate securities market has turned out to be a costly dead end for the plaintiffs bar. But until Monday lawyers at Girard Gibbs representing a proposed class of ARS purchasers held out hope that their claims against Merrill Lynch might be revived.

November 04, 2005 |

Newsbriefs

4 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources